|
1
|
Franceschi RT: The developmental control
of osteoblast-specific gene expression: Role of specific
transcription factors and the extracellular matrix environment.
Crit Rev Oral Biol Med. 10:40–57. 1999. View Article : Google Scholar
|
|
2
|
Park H, Noh AL, Kang JH, Sim JS, Lee DS
and Yim M: Peroxiredoxin II negatively regulates
lipopolysaccharide-induced osteoclast formation and bone loss via
JNK and STAT3. Antioxid Redox Signal. 22:63–77. 2015. View Article : Google Scholar :
|
|
3
|
Diddle AW and Smith IQ: Postmenopausal
osteoporosis: The role of estrogens. South Med J. 77:868–874. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Canalis E, Economides AN and Gazzerro E:
Bone morphogenetic proteins, their antagonists, and the skeleton.
Endocr Rev. 24:218–235. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang C, Geng J and Jiang S: MicroRNAs in
regulation of osteogenic differentiation of mesenchymal stem cells.
Cell Tissue Res. Jul 18–2016.Epub ahead of print.
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vishal M, Vimalraj S, Ajeetha R, Gokulnath
M, Keerthana R, He Z, Partridge NC and Selvamurugan N:
MicroRNA-590-5p stabilizes Runx2 by targeting Smad7 during
osteoblast differentiation. J Cell Physiol. 232:371–380. 2017.
View Article : Google Scholar
|
|
10
|
Yan J, Guo D, Yang S, Sun H, Wu B and Zhou
D: Inhibition of miR-222-3p activity promoted osteogenic
differentiation of hBMSCs by regulating Smad5-RUNX2 signal axis.
Biochem Biophys Res Commun. 470:498–503. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu Z, Wang Y, Sun Z, Wang H, Zhou H, Zhang
L, Zhang S and Cao X: miRNA-132-3p inhibits osteoblast
differentiation by targeting Ep300 in simulated microgravity. Sci
Rep. 5:186552015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fukuda T, Ochi H, Sunamura S, Haiden A,
Bando W, Inose H, Okawa A, Asou Y and Takeda S: MicroRNA-145
regulates osteoblastic differentiation by targeting the
transcription factor Cbfb. FEBS Lett. 589:3302–3308. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen D, Zhao M and Mundy GR: Bone
morphogenetic proteins. Growth Factors. 22:233–241. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Komori T, Yagi H, Nomura S, Yamaguchi A,
Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, et al:
Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell.
89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ducy P, Zhang R, Geoffroy V, Ridall AL and
Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast
differentiation. Cell. 89:747–754. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakashima K, Zhou X, Kunkel G, Zhang Z,
Deng JM, Behringer RR and de Crombrugghe B: The novel zinc
finger-containing transcription factor osterix is required for
osteoblast differentiation and bone formation. Cell. 108:17–29.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takayanagi H, Kim S, Koga T and Taniguchi
T: Stat1-mediated cytoplasmic attenuation in osteoimmunology. J
Cell Biochem. 94:232–240. 2005. View Article : Google Scholar
|
|
18
|
Kim S, Koga T, Isobe M, Kern BE, Yokochi
T, Chin YE, Karsenty G, Taniguchi T and Takayanagi H: Stat1
functions as a cytoplasmic attenuator of Runx2 in the
transcriptional program of osteoblast differentiation. Genes Dev.
17:1979–1991. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takayanagi H, Ogasawara K, Hida S, Chiba
T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, et al:
T-cell-mediated regulation of osteoclastogenesis by signalling
cross-talk between RANKL and IFN-gamma. Nature. 408:600–605. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takayanagi H, Kim S, Matsuo K, Suzuki H,
Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, et al: RANKL
maintains bone homeostasis through c-Fos-dependent induction of
interferon-beta. Nature. 416:744–749. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fujie A, Funayama A, Miyauchi Y, Sato Y,
Kobayashi T, Kanagawa H, Katsuyama E, Hao W, Tando T, Watanabe R,
et al: Bcl6 promotes osteoblastogenesis through Stat1 inhibition.
Biochem Biophys Res Commun. 457:451–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang CC, Ye BH, Chaganti RS and
Dalla-Favera R: BCL-6, a POZ/zinc-finger protein, is a
sequence-specific transcriptional repressor. Proc Natl Acad Sci
USA. 93:6947–6952. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jardin F, Ruminy P, Bastard C and Tilly H:
The BCL6 proto-oncogene: A leading role during germinal center
development and lymphomagenesis. Pathol Biol (Paris). 55:73–83.
2007. View Article : Google Scholar
|
|
24
|
Zou Q, Tan S, Yang Z, Wang J, Xian J,
Zhang S, Jin H, Yang L, Wang L and Zhang L: The human nucleophosmin
1 mutation A inhibits myeloid differentiation of leukemia cells by
modulating miR-10b. Oncotarget. 7:71477–71490. 2016.PubMed/NCBI
|
|
25
|
Foley NH, Bray I, Watters KM, Das S, Bryan
K, Bernas T, Prehn JH and Stallings RL: MicroRNAs 10a and 10b are
potent inducers of neuroblastoma cell differentiation through
targeting of nuclear receptor corepressor 2. Cell Death Differ.
18:1089–1098. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Okamoto H, Matsumi Y, Hoshikawa Y, Takubo
K, Ryoke K and Shiota G: Involvement of microRNAs in regulation of
osteoblastic differentiation in mouse induced pluripotent stem
cells. PLoS One. 7:e438002012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang
W, Jafferji M, Gordon JA, Li Z, Croce CM, van Wijnen AJ, Stein JL,
et al: miR-218 directs a Wnt signaling circuit to promote
differentiation of osteoblasts and osteomimicry of metastatic
cancer cells. J Biol Chem. 287:42084–42092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Boyce BF, Rosenberg E, de Papp AE and
Duong LT: The osteoclast, bone remodelling and treatment of
metabolic bone disease. Eur J Clin Invest. 42:1332–1341. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Wang B, Chen LQ, Yang J, Gong ZQ,
Zhao XL, Zhang CQ and Du KL: miR-10b promotes invasion by targeting
KLF4 in osteosarcoma cells. Biomed Pharmacother. 84:947–953. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Knirsh R, Ben-Dror I, Modai S, Shomron N
and Vardimon L: MicroRNA 10b promotes abnormal expression of the
proto-oncogene c-Jun in metastatic breast cancer cells. Oncotarget.
7:59932–59944. 2016.PubMed/NCBI
|
|
31
|
Wang X, Ling CC, Li L, Qin Y, Qi J, Liu X,
You B, Shi Y, Zhang J, Jiang Q, et al: MicroRNA-10a/10b represses a
novel target gene mib1 to regulate angiogenesis. Cardiovasc Res.
110:140–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Giusti J, Pinhal D, Moxon S, Campos CL,
Münsterberg A and Martins C: MicroRNA-10 modulates Hox genes
expression during Nile tilapia embryonic development. Mech Dev.
140:12–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duan S, Cermak L, Pagan JK, Rossi M,
Martinengo C, di Celle PF, Chapuy B, Shipp M, Chiarle R and Pagano
M: FBXO11 targets BCL6 for degradation and is inactivated in
diffuse large B-cell lymphomas. Nature. 481:90–93. 2012. View Article : Google Scholar :
|
|
34
|
Wu Q, Liu X, Yan H, He YH, Ye S, Cheng XW,
Zhu GL, Wu WY, Wang XN, Kong XJ, et al: B-cell lymphoma 6 protein
stimulates oncogenicity of human breast cancer cells. BMC Cancer.
14:4182014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nance JP, Bélanger S, Johnston RJ, Hu JK,
Takemori T and Crotty S: Bcl6 middle domain repressor function is
required for T follicular helper cell differentiation and utilizes
the corepressor MTA3. Proc Natl Acad Sci USA. 112:13324–13329.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu X, Lu H, Chen T, Nallaparaju KC, Yan
X, Tanaka S, Ichiyama K, Zhang X, Zhang L, Wen X, et al:
Genome-wide analysis identifies Bcl6-controlled regulatory networks
during T follicular helper cell differentiation. Cell Rep.
14:1735–1747. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu G and Zhao K: Looping around Bcl6 in
germinal center to sharpen B cell immunity. Immunity. 45:459–461.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ying Z, Mei M, Zhang P, Liu C, He H, Gao F
and Bao S: Histone arginine methylation by PRMT7 controls germinal
center formation via regulating Bcl6 transcription. J Immunol.
195:1538–1547. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miyauchi Y, Ninomiya K, Miyamoto H,
Sakamoto A, Iwasaki R, Hoshi H, Miyamoto K, Hao W, Yoshida S,
Morioka H, et al: The Blimp1-Bcl6 axis is critical to regulate
osteoclast differentiation and bone homeostasis. J Exp Med.
207:751–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Park-Min KH, Lee EY, Moskowitz NK, Lim E,
Lee SK, Lorenzo JA, Huang C, Melnick AM, Purdue PE, Goldring SR, et
al: Negative regulation of osteoclast precursor differentiation by
CD11b and β2 integrin-B-cell lymphoma 6 signaling. J Bone Miner
Res. 28:135–149. 2013. View Article : Google Scholar
|
|
41
|
Swarnkar G, Shim K, Nasir AM, Seehra K,
Chen HP, Mbalaviele G and Abu-Amer Y: Myeloid deletion of nemo
causes osteopetrosis in mice owing to upregulation of
transcriptional repressors. Sci Rep. 6:298962016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Morita M, Yoshida S, Iwasaki R, Yasui T,
Sato Y, Kobayashi T, Watanabe R, Oike T, Miyamoto K, Takami M, et
al: Smad4 is required to inhibit osteoclastogenesis and maintain
bone mass. Sci Rep. 6:352212016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, He X, Wei W and Zhou X: MicroRNA-194
promotes osteoblast differentiation via downregulating STAT1.
Biochem Biophys Res Commun. 460:482–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiao WZ, Gu XC, Hu B, Liu XW, Zi Y and Li
M: Role of microRNA-129-5p in osteoblast differentiation from bone
marrow mesenchymal stem cells. Cell Mol Biol (Noisy-le-grand).
62:95–99. 2016.
|
|
45
|
Tajima K, Takaishi H, Takito J, Tohmonda
T, Yoda M, Ota N, Kosaki N, Matsumoto M, Ikegami H, Nakamura T, et
al: Inhibition of STAT1 accelerates bone fracture healing. J Orthop
Res. 28:937–941. 2010.PubMed/NCBI
|
|
46
|
Yoshida K, Okamura H, Amorim BR, Hinode D,
Yoshida H and Haneji T: PKR-mediated degradation of STAT1 regulates
osteoblast differentiation. Exp Cell Res. 315:2105–2114. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tryndyak VP, Ross SA, Beland FA and
Pogribny IP: Downregulation of the microRNAs miR-34a, miR-127, and
miR-200b in rat liver during hepatocarcinogenesis induced by a
methyl-deficient diet. Mol Carcinog. 48:479–487. 2009. View Article : Google Scholar
|
|
48
|
Martín-Pérez D, Vargiu P, Montes-Moreno S,
León EA, Rodríguez-Pinilla SM, Lisio LD, Martínez N, Rodríguez R,
Mollejo M, Castellvi J, et al: Epstein-Barr virus microRNAs repress
BCL6 expression in diffuse large B-cell lymphoma. Leukemia.
26:180–183. 2012. View Article : Google Scholar
|
|
49
|
Nazari-Jahantigh M, Wei Y, Noels H, Akhtar
S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, et
al: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in
macrophages. J Clin Invest. 122:4190–4202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen J, Wang M, Guo M, Xie Y and Cong YS:
miR-127 regulates cell proliferation and senescence by targeting
BCL6. PLoS One. 8:e802662013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F
and Li D: MicroRNA-187-3p mitigates non-small cell lung cancer
(NSCLC) development through Downregulation of BCL6. Biochem Biophys
Res Commun. 471:82–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Huang F, Jin Y and Wei Y: MicroRNA-187
induces diffuse large B-cell lymphoma cell apoptosis via targeting
BCL6. Oncol Lett. 11:2845–2850. 2016.PubMed/NCBI
|
